Saralasin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameSaralasin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II receptor antagonists
TargetsAngiotensin II receptor
Therapy Area/IndicationsHeart FailureArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaGermany
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer Schering Pharma Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer Schering Pharma Gmbh
Active IndicationsN/A
Inactive IndicationsHeart FailureArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A